PHI Peptides – General Terms and Conditions of Sale
Version 1.2 | 19 November 2026 | Updated UAE working draft – subject to legal, regulatory and operational approval
Research-use-only Products are strictly for laboratory research and must never be administered to humans or animals. Separately classified prescription Products, where lawfully available, follow an independent clinical assessment, prescription and licensed supply pathway. A prescription does not convert a research-use-only Product into a medicine.
1. Who we are and how these Terms work
1.1 These terms and conditions (the “Terms”) apply to every order for products (“Products”) and services (“Services”) placed with NADXCHANGE TRADING – FZCO, trading as PHI Peptides, a free zone company incorporated in Dubai, United Arab Emirates, registration number 76712, trade licence number 78461, licensed by Dubai Integrated Economic Zones Authority (DIEZA), with its registered premises at IFZA Business Park, Premises 78461-001, Dubai Silicon Oasis, Dubai, United Arab Emirates (“PHI”, “we”, “us”), by the person or organisation placing the order (the “Purchaser”, “you”).
1.2 These Terms, together with the Order Confirmation, any quotation or invoice, and any Supplemental Terms, form the entire agreement between PHI and the Purchaser (the “Agreement”). “Sales Documents” means any quotation, invoice, Order Confirmation, dispatch note or other document we issue during the sales process. “Order Confirmation” means our written or electronic confirmation that we accept an order. If PHI and the Purchaser have signed a separate written contract covering particular Products, that contract prevails wherever it conflicts with these Terms.
1.3 These Terms prevail over any terms the Purchaser proposes, whenever they are proposed. Fulfilling an order is not acceptance of the Purchaser’s terms and does not change these Terms.
1.4 The PHI Partner Programme, consultations and professional/prescription supply are separate arrangements delivered, as applicable, through independently licensed clinical, pharmacy and other professional partners. Each is subject to its own Supplemental Terms, eligibility checks, privacy disclosures and required local approvals. PHI does not represent that its UAE trade licence authorises it to prescribe, dispense or provide healthcare. Where Supplemental Terms conflict with these Terms, the Supplemental Terms prevail for the relevant service.
1.5 An order placed through our website, by email or by message is an offer to buy. The Agreement is formed when we send an Order Confirmation or dispatch the Products, whichever happens first. We may decline an order, for example where a Product is unavailable, a price is shown in error, we cannot verify the Purchaser’s eligibility, or we reasonably believe the order would breach Section 3 or Section 11. Once the Agreement is formed, the Purchaser may not change or cancel it without our written consent, and we may charge any costs we have already incurred.
2.0 Product pathways. A Product identified as “research use only” may only be bought for lawful laboratory research and cannot be redirected to an individual patient. An individually prescribed product must be separately classified, authorised and supplied through a lawful professional channel. The product pages and checkout must clearly distinguish these pathways.
2. Who may buy
2.1 We supply Research Products only to eligible businesses, research institutions, laboratories and appropriately qualified professionals for lawful laboratory purposes. Individual customers may purchase only distinctly classified, legally supplied prescription Products through the separate professional pathway, after completing the applicable PHI medical questionnaire, receiving a valid prescription from a doctor acting through an appropriately licensed clinical provider, and accepting the applicable terms, informed consent and disclaimers. All customers must be aged 18 or older. Eligibility is verified before any order is accepted; an individual must never receive a Research Product for personal use.
2.2 We may require institutional details, identity and age verification, professional registration, an import licence or end-use declaration. For an eligible individual prescription order, the independent clinical provider must verify the questionnaire, undertake any required assessment and issue a valid prescription before the relevant licensed pharmacy or supplier accepts supply. We may decline or suspend an order if eligibility, legal classification, prescription validity, licensing or destination-country rules cannot be verified.
2.3 The Purchaser must keep its account credentials confidential, is responsible for all activity under its account, and must tell us promptly if it suspects unauthorised use.
3. Use of Products
3.1 The Purchaser must (a) follow all instructions, limitations, specifications, storage and handling requirements and conditions of use that we make available, including product information, certificates of analysis, safety data sheets and labelling (together, “Use Documents”), and (b) properly test, handle, store and use the Products.
3.2 Research use only. Products described or labelled as for research (“Research Products”) are supplied solely for in vitro laboratory research and analytical purposes. They are not medicines, medical devices, foods, dietary supplements or cosmetics. They are not for human or animal use of any kind, including injection, ingestion, inhalation or application to the body, and not for diagnostic or therapeutic use. The Purchaser must not administer Research Products to any human or animal, or incorporate them into any product intended for such use. The Purchaser has no express or implied permission from us to use Research Products for any other purpose.
3.3 Unless the Use Documents expressly say otherwise, Products have not been tested for safety or efficacy for any use. The Purchaser is solely responsible for (a) obtaining any intellectual property permissions needed for its use of the Products, (b) complying with all applicable laws, regulatory requirements, ethical approvals, licensing conditions and industry standards for its research, (c) testing and verifying that the Products are suitable for its intended purpose, and (d) ensuring the Products are handled, stored and disposed of safely by suitably trained people in suitably equipped facilities.
3.4 Prescription and other regulated Products are entirely separate from Research Products. Any individual patient pathway requires a clinically appropriate assessment and a valid prescription issued by a duly licensed doctor acting through the relevant licensed clinical service, together with lawful dispensing or supply by an appropriately authorised party. Completion of a questionnaire or signature on a disclaimer alone never authorises the supply of a medicine. The product, prescriber, pharmacy, fulfilment route and destination must each be lawful in the relevant jurisdictions. Where a regulatory approval or import authorisation is required but unavailable, no sale or shipment will proceed.
3.5 The Purchaser must not resell, distribute, repackage, relabel or export Products, or supply them to anyone for a use prohibited by this Section, without our prior written consent. This does not apply to participants in an approved PHI programme who are acting within their Supplemental Terms.
3.6 Information on our Website and general education materials is educational and is not a substitute for medical advice. Any clinical advice, prescribing, consent or follow-up is the responsibility of the separately licensed healthcare provider under its own professional terms and privacy notice. No marketing or disclaimer overrides clinical duties or applicable statutory rights.
4. Delivery, storage and risk
4.1 Delivery and performance dates are estimates only. Time is not of the essence, and we are not liable for delay.
4.2 PHI fulfils orders from authorised logistics or supply facilities in multiple countries, depending on product classification, availability, regulatory authorisations and destination. The actual dispatch origin, responsible seller/supplier, delivery charge, destination, required storage standard and any applicable Incoterm will be stated in the Order Confirmation or applicable Supplemental Terms. Unless otherwise agreed, delivery is to the accepted address and risk passes as permitted by applicable mandatory law. Separate licensed suppliers may fulfil regulated products under their own legal responsibilities.
4.3 Some Products are temperature-sensitive and must be stored as stated on the label or Use Documents, for example at 2–8 °C. The Purchaser must arrange for someone to receive the delivery, and must unpack, inspect and store the Products correctly straight away. We are not responsible for deterioration caused by delayed collection, an incorrect or incomplete address, customs or regulatory holds, or incorrect storage after delivery.
4.4 We do not accept orders for delivery to Greece or the United Arab Emirates. We also do not ship to any other country or territory where the relevant product, transaction, recipient or route is restricted or prohibited, or where required authorisations are unavailable. We may amend the restricted-country list at any time. International availability is assessed per product and order; global website access does not mean every product may be supplied globally. The parties must each obtain permits and clearances legally assigned to them, and shipments may be refused where compliance cannot be confirmed.
4.5 We may make partial shipments and invoice for each one. The Purchaser must pay for the units shipped whether or not the order is complete.
4.6 For certain Products we may require the purchase of whole lots, limit quantities, or allocate available supply among customers at our discretion. We are not liable for any failure to supply that results.
5. Inspection and nonconforming Products
5.1 The Purchaser should inspect Products promptly on delivery. Please report visible damage, leakage, broken seals or temperature-monitoring issues to [email protected] within 48 hours where reasonably practicable, and other apparent nonconformities within five (5) days, with order details and evidence. These notification windows support prompt investigation and do not remove mandatory rights or remedies for latent defects, unsafe Products or other matters that cannot lawfully be excluded.
5.2 “Nonconforming Products” means Products, or quantities, that differ from those in the Order Confirmation, or that arrive damaged or compromised.
5.3 If notice is given in time, we will, at our choice, replace the Nonconforming Products or credit or refund their price (adjusting the invoice for any short delivery). We may inspect the Products or ask for samples to be returned. These remedies are the Purchaser’s only remedies for Nonconforming Products.
6. Prices and payment
6.1 Prices are those shown on our website, in our quotation or on our published price list at the date of the Order Confirmation, in the currency shown. If we discover a pricing error we will tell the Purchaser before charging any higher price, and the Purchaser may then cancel the affected order.
6.2 Prices exclude VAT, sales and excise taxes, duties, customs charges, tariffs and similar charges imposed by any authority, which are the Purchaser’s responsibility, other than taxes on our own income or property. If new or increased tariffs raise our cost of supplying the Products, we may adjust prices or add a surcharge, and we will tell the Purchaser before dispatch.
6.3 Payment is by bank transfer only, to the verified bank account specified on the PHI invoice or payment instructions. We do not accept card payments at website checkout. Unless specific invoice credit terms are agreed in writing, orders must be paid in full and cleared funds received before release or dispatch. Do not send funds to changed bank details without independent verification through an established PHI contact.
6.4 Overdue undisputed amounts may attract late-payment charges or interest only to the extent expressly agreed in a quotation or invoice and permitted under applicable UAE law. We may recover reasonable, documented collection costs where lawful and may suspend new orders after reasonable notice, subject to existing legal obligations. A specific interest rate and grace period must be approved by UAE counsel and Finance before publication.
6.5 The Purchaser may not withhold or set off any amount due to us because of a claim or dispute.
6.6 We receive bank-transfer transaction references, payer name, remittance information and payment status through our bank and Odoo records. We do not collect payment-card details or operate a card payment gateway for these sales.
7. Use Documents, website content and intellectual property
7.1 We may supply Use Documents with the Products. The Purchaser may use them only to support its use of those Products, and must not alter them or present them out of context.
7.2 All trademarks (including PHI and the PHI mark), logos, website content, text, images, video, product information, education materials and Use Documents belong to us or our licensors. No right is granted to the Purchaser except a limited, non-transferable right to use them internally as set out in this Section. The Purchaser must not use our name, marks or content in marketing or publicity, or describe the Products as having approvals, claims or properties not stated in the Use Documents, without our prior written consent.
7.3 The Purchaser must not misuse our website, including by scraping it, interfering with its operation or attempting to gain unauthorised access. The website is provided as available and may occasionally be unavailable.
8. Limited warranties
8.1 Subject to the Product’s particular written specification, certificate of analysis, expiry or retest date and agreed storage conditions, we warrant conformity to the published specifications at the point of shipment. Any continuing stability warranty applies only if expressly identified in the Order Confirmation or Product documentation, and does not extend past the labelled expiry. This clause does not limit mandatory duties concerning safety, quality or lawful supply.
8.2 We warrant that Services will be performed with reasonable skill and care. Any claim about Services must be made within ninety (90) days of performance.
8.3 Except for the warranties above, we give no warranty of any kind about the Products (including their use or any results), the Services or any information or technical assistance we provide. This includes any warranty of merchantability, fitness for a particular purpose or non-infringement of third-party intellectual property rights, whether express or implied by law, course of dealing or trade usage, to the fullest extent permitted by law. Any suggestion we make about the use, selection or suitability of a Product is not a warranty.
8.4 The warranties do not apply unless the Purchaser (a) gives us written notice of the defect immediately on discovering it, (b) gives us a reasonable opportunity to examine the Products, and (c) the defect is verified by us.
8.5 The warranty in Section 8.1 does not apply if (a) the Purchaser has breached Section 3, (b) the Products have been stored, handled, reconstituted, diluted, altered or contaminated otherwise than in line with the Use Documents, (c) the Products are used after their expiry or retest date, or (d) the problem results from normal degradation or from events after delivery outside our control.
8.6 Where a warranty claim is valid, we will, at our choice, replace the Products or re-perform the Services, or credit or refund the price. This is the Purchaser’s sole and exclusive remedy and our entire liability for breach of warranty.
8.7 Any exclusion of implied conditions or warranties operates only to the extent permitted by applicable UAE law and any mandatory law of the Purchaser’s destination country. No provision removes statutory rights or regulatory duties that cannot lawfully be excluded.
9. Returns
Products may not be returned without our prior written authorisation, except where return, replacement, refund, recall or other remedy is required by mandatory law. For safety, traceability and temperature-control reasons, change-of-mind returns of sterile, temperature-sensitive, custom-made, opened or unsealed Products are not normally accepted. We will provide safe return or disposal instructions for defective, recalled or otherwise nonconforming Products. Any agreed restocking fee must be disclosed in advance and permitted by law.
10. Liability and indemnity
10.1 The Purchaser accepts all risk and liability for loss, damage or injury to people or property arising from the transport, storage, handling or use of the Products after delivery, including any use not permitted by Section 3, and including any infringement of third-party intellectual property rights resulting from its particular use of the Products.
10.2 The Purchaser will indemnify and hold harmless PHI, its affiliates, and their directors, employees and agents against all claims, losses, damages, costs and expenses (including reasonable legal fees) arising from (a) the storage, handling, sale, supply or use of the Products by or for the Purchaser, (b) the Purchaser’s breach of the Agreement, in particular Sections 3 and 11, or (c) the negligence or wilful misconduct of the Purchaser, its affiliates, agents or subcontractors.
10.3 Subject to Section 10.4 and any mandatory applicable law, neither party is liable for indirect or consequential losses, including lost profit, revenue, goodwill or business opportunities, arising from ordinary breach of the Agreement. PHI’s aggregate contractual liability relating to an affected order is limited to the amount paid for the Products or Services giving rise to the claim, only to the extent such limitation is valid and enforceable under the applicable law. This limitation does not prevent any remedy that cannot lawfully be restricted.
10.4 Nothing in this Agreement excludes or limits liability for fraud, wilful misconduct, death or personal injury where exclusion is prohibited, a legally binding product-safety or recall obligation, infringement of mandatory consumer or other statutory rights, or any other liability that cannot be limited under applicable law. The Purchaser remains obliged to pay sums properly due.
11. Compliance with laws
11.1 Each party shall comply with all laws applicable to its own activities, including UAE federal and Dubai legislation, DIEZA/IFZA licence conditions, medical-product and healthcare rules, research-only labelling, professional licensing, data protection, anti-bribery and import/export requirements of the relevant shipping and destination countries. PHI ships from multiple authorised fulfilment locations but does not ship into Greece or the UAE. For individually prescribed Products, the independent clinical provider is responsible for professional assessment and prescriptions; a suitably licensed pharmacy or authorised supplier is responsible for dispensing where required. A UAE trade licence alone does not confer medicines marketing or healthcare rights in other countries.
11.2 Neither party shall engage in any transaction prohibited by sanctions, export controls or other trade restrictions legally applicable to that party or the transaction, including applicable UAE and United Nations requirements and any other applicable destination or payment-channel restrictions. We may request reasonable end-user, trade-compliance and licensing information before accepting or fulfilling an order.
11.3 We may refuse, cancel or suspend any order or supply, and may report to the relevant authorities, if we reasonably suspect that the Purchaser is in breach of this Section or Section 3, or that Products are being diverted or misused. We are not liable for any resulting loss.
11.4 On reasonable notice the Purchaser must give us information we reasonably need to check its compliance with Sections 3 and 11. Any breach of Section 11 is a material breach of the Agreement.
12. Suspension and termination
In addition to our other rights, we may suspend or terminate the Agreement, any order and the Purchaser’s account immediately by written notice if the Purchaser (a) fails to pay any amount when due, (b) breaches the Agreement, including Sections 2, 3 or 11, (c) gives us false or misleading information, (d) becomes insolvent, enters bankruptcy, administration, liquidation or a similar process, or makes an arrangement with its creditors, (e) becomes, or its dealings with us become, subject to sanctions, or (f) we reasonably believe the Products are being misused or diverted. Rights and obligations that have already arisen are not affected.
13. Confidential information
All non-public information that we disclose to the Purchaser, including pricing, specifications, supplier and sourcing details, unpublished documents and business information, whether or not marked confidential, must be kept confidential and used only to perform the Agreement. On request the Purchaser must promptly return or destroy it. We may seek an injunction to prevent a breach of this Section. It does not apply to information that is public, was already known to the Purchaser, was lawfully received from a third party without a duty of confidentiality, or must be disclosed by law (in which case the Purchaser must, where lawful, tell us first).
14. Force majeure
Neither party is in breach of the Agreement, other than for payment obligations, to the extent performance is prevented or delayed by an event beyond its reasonable control. Such events include natural disaster, war, terrorism, riot, epidemic or pandemic, fire, labour disputes, laws or orders of any government or regulator (including new import or export restrictions), customs or regulatory holds, carrier or cold-chain failure outside our control, shortage of raw materials or labour, and failure of utilities or internet services. The affected party must notify the other promptly, take reasonable steps to limit the effect, and resume performance as soon as it can. If an event continues for more than sixty (60) days, either party may cancel the affected order, and we will refund any amount paid for Products not delivered.
15. Data protection
We process customer and professional account, order, eligibility, payment, delivery and support information as described in our Privacy Policy. Any medical questionnaire, consultation, clinical records and prescribing information must be handled under the privacy arrangements of the relevant separately licensed healthcare provider, with only the minimum information shared with PHI or the lawful fulfilment partner for eligibility and supply.
16. General
16.1 No waiver. A waiver by us is effective only if given in writing. A delay or failure to exercise a right is not a waiver.
16.2 Assignment. The Purchaser may not assign or transfer any right or obligation under the Agreement without our prior written consent. We may assign our rights and obligations to an affiliate or a successor to our business.
16.3 Relationship. The parties are independent contractors. Nothing in the Agreement creates a partnership, joint venture, agency, employment or fiduciary relationship.
16.4 Third parties. Except where mandatory law provides otherwise or a written contract expressly grants rights, the Agreement is intended for the parties and their permitted successors and assigns, and does not confer contractual enforcement rights on unrelated third parties.
16.5 Severability. If any provision is found invalid or unenforceable, the rest of the Agreement is unaffected.
16.6 Survival. Provisions that by their nature are meant to continue after the Agreement ends will continue, including Sections 3, 7, 8, 10, 13 and 16.
16.7 Changes. We may update these Terms from time to time. The version in force on the date of the Order Confirmation applies to that order. Any other change to an Agreement must be in writing and signed by both parties.
16.8 Notices. Notices to us must be in writing and sent by tracked courier or registered post to our registered office, with a copy by email to [email protected]. Notices to the Purchaser may be sent to the address or email on its account or order. An email is treated as received on the next business day.
16.9 Language. The working language of this Agreement is English. Where Arabic wording is required by UAE law or a competent authority, an Arabic version shall be provided and the legally applicable language-precedence rules shall govern. Nothing in this clause overrides mandatory Arabic-language requirements.
16.10 Governing law and courts. This Agreement is governed by the applicable federal laws of the United Arab Emirates and the laws in force in the Emirate of Dubai, without prejudice to mandatory laws applicable to a particular transaction. Subject to mandatory jurisdiction rules, the courts of Dubai, United Arab Emirates, have jurisdiction over disputes arising from this Agreement. The parties exclude the United Nations Convention on Contracts for the International Sale of Goods to the extent its exclusion is lawful and relevant. UAE-qualified counsel must confirm this forum clause before publication; no DIFC Courts opt-in is assumed.
17. Contact us
Order enquiries: [email protected]
Wholesale enquiries: [email protected]
General information: [email protected]
Telephone and WhatsApp: +44 7448 086015
Registered premises: IFZA Business Park, Premises 78461-001, Dubai Silicon Oasis, Dubai, United Arab Emirates